These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1680586)

  • 21. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension.
    Hirooka Y; Kishi T; Sakai K; Takeshita A; Sunagawa K
    Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R818-26. PubMed ID: 21289238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological basis for antihypertensive therapy with a novel dopamine agonist.
    Haeusler G; Lues I; Minck KO; Schelling P; Seyfried CA
    Eur Heart J; 1992 Sep; 13 Suppl D():129-35. PubMed ID: 1356783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presynaptic alpha2-receptors regulate reverse Na+/Ca2+-exchange and transmitter release in Na+-loaded peripheral sympathetic nerves.
    Török TL; Nagykáldi Z; Sáska Z; Kovács T; Nada SA; Zilliikens S; Magyar K; Sylvester Vizi E
    Neurochem Int; 2004 Oct; 45(5):699-711. PubMed ID: 15234113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presynaptic receptors in hypertension.
    Borkowski KR
    Ann N Y Acad Sci; 1990; 604():389-97. PubMed ID: 2171400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endoplasmic reticulum and regulation of neuromediator release in presynaptic terminals].
    Verkhrats'kyĭ ON; Fedulova SA
    Fiziol Zh (1994); 2004; 50(4):142-9. PubMed ID: 15460039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- and postsynaptic adrenergic dysfunctions in hypertension.
    de Champlain J
    J Hypertens Suppl; 1990 Dec; 8(7):S77-85. PubMed ID: 1965658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of alpha2-adrenergic receptors and cyclic adenosine monophosphate-dependent protein kinase in the regulation of norepinephrine release in the central nervous system of spontaneously hypertensive rats.
    Tsuda K; Tsuda S; Nishio I
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S81-5. PubMed ID: 14871035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epinephrine and dopamine on norepinephrine release from the sympathetic nerve endings in hypertension.
    Tsuda K; Kuchii M; Nishio I; Masuyama Y
    J Hypertens Suppl; 1986 Dec; 4(5):S45-8. PubMed ID: 3471913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter release mechanisms in autonomic nerve terminals.
    Cunnane TC; Searl TJ
    Adv Second Messenger Phosphoprotein Res; 1994; 29():425-59. PubMed ID: 7848725
    [No Abstract]   [Full Text] [Related]  

  • 30. Catecholamines and blood pressure regulation.
    Mannelli M; Pupilli C; Lanzillotti R; Ianni L; Serio M
    Horm Res; 1990; 34(3-4):156-60. PubMed ID: 2104398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotransmitter Switching Coupled to β-Adrenergic Signaling in Sympathetic Neurons in Prehypertensive States.
    Bardsley EN; Davis H; Buckler KJ; Paterson DJ
    Hypertension; 2018 Jun; 71(6):1226-1238. PubMed ID: 29686017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotransmitter Release Can Be Stabilized by a Mechanism That Prevents Voltage Changes Near the End of Action Potentials from Affecting Calcium Currents.
    Clarke SG; Scarnati MS; Paradiso KG
    J Neurosci; 2016 Nov; 36(45):11559-11572. PubMed ID: 27911759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotransmitter release mechanisms in sympathetic and parasympathetic nerve terminals.
    Searl TJ; Cunnane TC
    Biochem Soc Trans; 1993 May; 21(2):416-20. PubMed ID: 8103006
    [No Abstract]   [Full Text] [Related]  

  • 35. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen.
    Elenkov IJ; Vizi ES
    Neuropharmacology; 1991 Dec; 30(12A):1319-24. PubMed ID: 1686302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptic inhibition in the hippocampus.
    Thompson SM; Capogna M; Scanziani M
    Trends Neurosci; 1993 Jun; 16(6):222-7. PubMed ID: 7688163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoreceptors do not regulate routinely neurotransmitter release: focus on adrenergic systems.
    Kalsner S
    J Neurochem; 2001 Aug; 78(4):676-84. PubMed ID: 11520888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CaMKII Regulates Synaptic NMDA Receptor Activity of Hypothalamic Presympathetic Neurons and Sympathetic Outflow in Hypertension.
    Li DP; Zhou JJ; Zhang J; Pan HL
    J Neurosci; 2017 Nov; 37(44):10690-10699. PubMed ID: 28972129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea.
    Fletcher EC
    Sleep; 2003 Feb; 26(1):15-9. PubMed ID: 12627727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.
    Bücheler MM; Hadamek K; Hein L
    Neuroscience; 2002; 109(4):819-26. PubMed ID: 11927164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.